Company: RCUS
Filing Date: 2025-10-06
Form Type: 8-K
Source: 0001724521-25-000107
Chunk: 3

Company: Arcus Biosciences, Inc.
Filing Date: 2025-10-06
Form: 8-K
Item: Item 8.01
Chunk 3
---
 and uncertainties facing the Company are described more fully in the “ Risk Factors” section of Company’s most recent periodic report filed with the U. S. Securities and Exchange Commission (“ SEC”) and in other filings that the Company makes with the SEC from time to time, which are available at www. sec. gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any obligation or undertaking to update, supplement or revise any forward-looking statements contained in this press release, except to the extent required by law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                             ARCUS BIOSCIENCES, INC.                                     
  Date: October 6, 2025      By:                          /s/ Terry Rosen, Ph. D.        
                                                          Terry Rosen, Ph. D.            
                                                          Chief Executive Officer